Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Arnold

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Journal of Periodontology|October 1, 1993
Effects of a combination therapy to eliminate Porphyromonas gingivalis in refractory periodontitisJ G Collins, S Offenbacher, R R Arnold
Journal of Immunological Methods|May 4, 1987
Separation of human IgA1 and IgA2 using jacalin-agarose chromatographyR L Gregory, J Rundegren, R R Arnold
Infection and Immunity|August 1, 1976
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and salivaR R Arnold, J Mestecky, J R McGhee
Canadian Journal of Microbiology|November 1, 1989
Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organismC A Bortner, R R Arnold, R D Miller
Infection and Immunity|July 1, 1983
Effects of alpha-amylase on in vitro growth of Legionella pneumophilaC A Bortner, R D Miller, R R Arnold
Infection and Immunity|February 1, 1986
Bactericidal effect of lactoferrin on Legionella pneumophilaC A Bortner, R D Miller, R R Arnold
Infection and Immunity|June 1, 1991
Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin GC W Cutler, J R Kalmar, R R Arnold
Infection and Immunity|June 1, 1991
Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalisC W Cutler, J R Kalmar, R R Arnold
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalisC W Cutler, R R Arnold, H A Schenkein
Clinical Immunology and Immunopathology|December 5, 1998
Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitusC L Bristow, F Di Meo, R R Arnold
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Journal of Periodontology|October 1, 1993
Effects of a combination therapy to eliminate Porphyromonas gingivalis in refractory periodontitisJ G Collins, S Offenbacher, R R Arnold
Journal of Immunological Methods|May 4, 1987
Separation of human IgA1 and IgA2 using jacalin-agarose chromatographyR L Gregory, J Rundegren, R R Arnold
Infection and Immunity|August 1, 1976
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and salivaR R Arnold, J Mestecky, J R McGhee
Canadian Journal of Microbiology|November 1, 1989
Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organismC A Bortner, R R Arnold, R D Miller
Infection and Immunity|July 1, 1983
Effects of alpha-amylase on in vitro growth of Legionella pneumophilaC A Bortner, R D Miller, R R Arnold
Infection and Immunity|February 1, 1986
Bactericidal effect of lactoferrin on Legionella pneumophilaC A Bortner, R D Miller, R R Arnold
Infection and Immunity|June 1, 1991
Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin GC W Cutler, J R Kalmar, R R Arnold
Infection and Immunity|June 1, 1991
Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalisC W Cutler, J R Kalmar, R R Arnold
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalisC W Cutler, R R Arnold, H A Schenkein
Clinical Immunology and Immunopathology|December 5, 1998
Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitusC L Bristow, F Di Meo, R R Arnold
Pageof 7